Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | THPO | P40225 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | LDHB | P07195 | 1/20 | 0.42 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetamide SCHEMBL20411642 | 1.00 | — | — | |
| Acetamide SCHEMBL4953249 | 1.00 | LMNA (1.00) | LMNAALOX15BLMPMP22ALDH1A1 | |
| Acetamide SCHEMBL20411579 | 1.00 | — | — | |
| Acetamide SCHEMBL6278917 | 1.00 | — | — | |
| Acetamide SCHEMBL20411649 | 1.00 | — | — | |
| Acetamide SCHEMBL2232674 | 1.00 | — | — | |
| Acetamide SCHEMBL5232 | 1.00 | — | — | |
| Acetamide SCHEMBL20411647 | 1.00 | — | — | |
| Acetamide SCHEMBL14990492 | 0.94 | — | — | |
| Acetamide SCHEMBL17287836 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111471445-B | Oil displacement agent of ligand gemini surfactant, preparation method and application thereof | 中国石油天然气股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-111471445-B | Oil displacement agent of ligand gemini surfactant, preparation method and application thereof | 中国石油天然气股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-111471445-B | Oil displacement agent of ligand gemini surfactant, preparation method and application thereof | 中国石油天然气股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| EP-3183249-A1 | 1,4,7,10-TETRAZACYCLODODECANE BASED AGENTS TO TARGET BACTERIA AND ITS USE | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2017-06-28 | — | — | EP | disclosed |
| WO-2016026841-A1 | 1,4,7,10-TETRAZACYCLODODECANE BASED AGENTS TO TARGET BACTERIA AND ITS USE | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2016-02-25 | — | — | WO | disclosed |
| US-8455641-B2 | Method for producing 4,4′-(propane-1,2-diyl)-dipiperazine-2,6-dione | CYATHUS EXQUIRERE PHARMAFORSCHUNGS GMBH (AT) | 2013-06-04 | — | — | US | disclosed |
| WO-2012081036-A2 | A PROCESS FOR PREPARATION OF 4,4'-(1-METHYL-1,2-ETHANDIYL)-BIS-(2,6-PIPERAZINEDIONE) | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-06-21 | — | — | WO | disclosed |
| US-20100152447-A1 | Novel Method for Producing 4,4-(1-Methyl-1,2-Ethanediyl)-BIS-(2,6-Piperazinedione) | CYATHUS EXQUIRERE PHARMAFORSCHUNGS GMBH (AT) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152447-A1 | Novel Method for Producing 4,4-(1-Methyl-1,2-Ethanediyl)-BIS-(2,6-Piperazinedione) | CPS1, ABAT, ALDH7A1 | LMNA 2032/4885ALOX15 2244/4885BLM 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.